100% Tariffs on Imported Brand-Name Drugs Announced by Trump Administration
The Trump administration has announced a 100% tariff on imported brand-name drugs, with significant caveats that may influence future trade negotiations.
8 articles tagged with "tariffs"
The Trump administration has announced a 100% tariff on imported brand-name drugs, with significant caveats that may influence future trade negotiations.
The Trump administration is negotiating new drug-pricing agreements with smaller pharmaceutical companies, influenced by potential tariffs.
Jamieson Greer has voiced dissatisfaction with the WTO's handling of ecommerce tariff negotiations, signaling a shift towards alternative strategies for tariff management.
An Indiana-based company is pushing for a return to domestic bicycle manufacturing, seeking tariffs to enhance competitiveness against imported products.
The Supreme Court's recent decision restricts the use of the International Emergency Economic Powers Act for tariff imposition, impacting future trade policies.
The Supreme Court's decision regarding Trump's IEEPA tariffs, deemed illegal, could result in refunds exceeding $165 billion, prompting calls for companies to allocate these funds to employee bonuses or raises.
This analysis explores the operational strategies drug manufacturers and distributors can adopt to bolster supply chain resilience in the face of tariffs and disruptions.
A recent judicial ruling permits companies to reclaim funds associated with tariffs imposed during the Trump administration, following a Supreme Court decision.